The ATP13A2 gene, also known as PARK9, plays a crucial role in the genetic landscape of Parkinson's disease, a progressive neurological disorder that affects movement. Mutations in the ATP13A2 gene are linked to a rare form of Parkinson's disease, often associated with early onset and additional symptoms beyond the classical movement issues, such as cognitive impairment and psychiatric symptoms.
The ATP13A2 Gene PARK9 Parkinson Genetic Test is a specialized diagnostic tool designed to detect mutations in the ATP13A2 gene. This test is particularly relevant for individuals who have a family history of Parkinson's disease or exhibit symptoms at an unusually young age. Identifying mutations in the ATP13A2 gene can aid in the accurate diagnosis of the condition, influence treatment strategies, and provide valuable information for family planning.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. DNA Labs UAE employs state-of-the-art technology and adheres to stringent quality control measures to ensure the accuracy and reliability of their test results.
The cost of the ATP13A2 Gene PARK9 Parkinson Genetic Test at DNA Labs UAE is 4400 AED. This price includes the collection of a DNA sample, usually through a blood draw or cheek swab, the genetic analysis, and a comprehensive report detailing the findings. Individuals interested in undergoing this test are advised to consult with a healthcare professional or a genetic counselor to discuss the potential implications of the test results for themselves and their family members.
The "GBA Gene Parkinson Disease Late-Onset Susceptibility to Genetic Test" is a specific diagnostic tool offered by DNA Labs UAE, designed to assess an individual's genetic predisposition to developing late-onset Parkinson's disease. This test focuses on mutations in the GBA gene, which have been linked to an increased risk of Parkinson's disease, a progressive neurological disorder that affects movement. The presence of certain mutations in the GBA gene can significantly elevate an individual's likelihood of developing this condition later in life.
At a cost of 4400 AED, the test provides a valuable insight for those who have a family history of Parkinson's disease or exhibit early symptoms, enabling them to take proactive measures in managing their health. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test involves a simple sample collection process, followed by comprehensive genetic analysis to identify any mutations associated with an increased risk of Parkinson's disease. The results from this test can guide individuals in making informed decisions regarding their health and lifestyle, potentially influencing treatment plans and preventive strategies to mitigate the impact of the disease.
The MT-TT gene, located within the mitochondrial genome, plays a crucial role in the proper functioning of mitochondria, the cell's energy-producing structures. Mutations in the MT-TT gene have been linked to an increased susceptibility to Parkinson's disease, a progressive neurological disorder characterized by motor symptoms such as tremors, stiffness, and bradykinesia, as well as non-motor symptoms. Understanding one's genetic predisposition to Parkinson's disease can be crucial for early detection, management, and potential preventive measures.
DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the MT-TT gene that may increase an individual's susceptibility to Parkinson's disease. This test is a valuable tool for those with a family history of Parkinson's or individuals who wish to assess their genetic risk for the disease. The test is priced at 4400 AED and involves a simple procedure to collect a DNA sample, typically through a blood draw or cheek swab. The collected sample is then analyzed in the lab to detect any genetic alterations in the MT-TT gene that might indicate a higher risk of developing Parkinson's disease.
Opting for the MT-TT related genetic test at DNA Labs UAE can empower individuals with crucial information about their health, allowing them to make informed decisions regarding their lifestyle, health monitoring, and potential interventions. It's an investment in one's health that could potentially alter the course of their life by providing the opportunity for early intervention and personalized health strategies.
The ATP6AP2 gene has been identified as a critical player in the development of a unique form of Parkinsonism characterized by spasticity, following an X-linked inheritance pattern. This condition, which combines features of Parkinson's disease with muscle stiffness and spasms, has led to the development of specialized genetic testing to diagnose the disorder accurately.
The genetic test for ATP6AP2 gene-related Parkinsonism with spasticity is available at DNA Labs UAE, a leading facility in genetic diagnostics. The test specifically targets mutations within the ATP6AP2 gene to confirm the diagnosis, enabling healthcare professionals to tailor treatment and management plans for affected individuals.
Priced at 4400 AED, the test is a valuable tool for families with a history of X-linked Parkinsonism with spasticity, offering them a clear understanding of their genetic status. This information is crucial for making informed decisions about future healthcare and for understanding the risk to other family members.
The SLC6A3 gene Parkinsonism-Dystonia Infantile genetic test is a specialized diagnostic tool designed to detect mutations in the SLC6A3 gene, which have been associated with the development of Parkinsonism-Dystonia in infancy. This rare genetic disorder is characterized by a combination of Parkinsonian symptoms such as tremors, rigidity, and bradykinesia, alongside dystonia, which involves involuntary muscle contractions leading to abnormal postures or movements. Early detection through genetic testing can be crucial for managing symptoms and improving the quality of life for affected individuals.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis of the SLC6A3 gene to identify any mutations that may be present. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed using advanced genetic sequencing technologies.
The cost of the SLC6A3 gene Parkinsonism-Dystonia Infantile genetic test is 4400 AED. While the price may seem significant, the value of early and accurate diagnosis cannot be overstated, as it opens the door to targeted treatments and interventions that can significantly benefit the patient. Individuals with a family history of Parkinsonism-Dystonia or those showing early symptoms of the disorder are encouraged to consider this test. It's also advisable to consult with a healthcare provider or a genetic counselor to understand the implications of the test results fully.
The SLC2A1 gene is associated with a condition known as paroxysmal exercise-induced dyskinesia (PED), which can sometimes co-occur with epilepsy and/or hemolytic anemia. This condition is characterized by sudden, involuntary movements that are often triggered by prolonged exercise, stress, or fatigue. In some cases, individuals may also experience seizures or an abnormal breakdown of red blood cells, leading to hemolytic anemia.
The genetic test for this condition focuses on identifying mutations in the SLC2A1 gene, which provides instructions for making a protein that transports glucose across the blood-brain barrier. Glucose is the brain's primary energy source, and disruptions in its transport can lead to neurological symptoms.
DNA Labs UAE offers a comprehensive genetic test for diagnosing mutations in the SLC2A1 gene associated with paroxysmal exercise-induced dyskinesia, epilepsy, and/or hemolytic anemia. The test is priced at 4400 AED and involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to identify any genetic alterations in the SLC2A1 gene. This test is crucial for individuals exhibiting symptoms related to these conditions, as it can provide a definitive diagnosis, inform treatment strategies, and guide family planning decisions.
The PNKD Gene Paroxysmal Nonkinesigenic Dyskinesia Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the PNKD gene, which are linked to Paroxysmal Nonkinesigenic Dyskinesia (PNKD). This condition is characterized by sudden, involuntary movements that can include spasms, twisting motions, or flailing limbs, which occur without a specific trigger like sudden movement. Unlike other forms of dyskinesia, episodes are not initiated by kinesigenic activity and can last for minutes to hours.
The test is crucial for individuals showing symptoms of PNKD, as a positive identification of mutations in the PNKD gene can confirm the diagnosis, allowing for a tailored management plan. Early diagnosis can significantly improve the quality of life for individuals with PNKD by providing insights into potential triggers, effective treatments, and lifestyle adjustments.
At a cost of 4400 AED, the test is conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. The process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for specific genetic alterations in the PNKD gene. Results from this test can provide definitive answers for affected individuals and their families, guiding decisions about management and care.
The ARX Gene Partington Syndrome Genetic Test is a specialized diagnostic procedure conducted at DNA Labs UAE, aimed at identifying mutations in the ARX gene, which are known to cause Partington syndrome. This rare genetic disorder is characterized by intellectual disability, dystonic hand movements, and sometimes epilepsy. The test involves analyzing the patient's DNA to detect abnormalities in the ARX gene that may lead to the development of this condition.
The cost of the ARX Gene Partington Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This comprehensive test is crucial for families seeking a definitive diagnosis of Partington syndrome, enabling them to understand the genetic basis of the condition and to explore potential treatment options and management strategies. By identifying the specific mutation, healthcare providers can offer personalized care and support to affected individuals and their families.
The PLP1 gene Pelizaeus-Merzbacher Disease (PMD) genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the PLP1 gene, which are responsible for causing Pelizaeus-Merzbacher Disease. PMD is a rare, genetic, central nervous system disorder characterized by a range of neurological symptoms, including motor abilities impairment, cognitive development issues, and coordination problems. The test is crucial for early diagnosis, which can aid in managing symptoms and improving the quality of life for affected individuals. The cost of the test is 4400 AED, making it an accessible option for those seeking comprehensive genetic analysis in the UAE. This test is particularly valuable for families with a history of PMD, offering them crucial information for family planning and management of the condition.
The SLC16A2 gene Pelizaeus-Merzbacher Disease (PMD) genetic test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the SLC16A2 gene, which are linked to the development of Pelizaeus-Merzbacher Disease. PMD is a rare, genetic neurological disorder characterized by a progressive decline in motor abilities, coordination, and cognitive functions, resulting from the improper formation of myelin in the central nervous system. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing it for specific genetic alterations associated with the condition. With a cost of 4400 AED, this test provides crucial information for the accurate diagnosis and management of Pelizaeus-Merzbacher Disease, enabling targeted treatment plans and genetic counseling for affected families.
